Premium
High‐throughput analysis revealed the unique immunoglobulin gene rearrangements in plasmacytoma‐like post‐transplant lymphoproliferative disorder
Author(s) -
Hoshino Akihiro,
Nishimura Akira,
Naruto Takuya,
Okano Tsubasa,
Matsumoto Kazuaki,
Okamoto Keisuke,
Shintaku Hiroshi,
Tokoro Shown,
Okamoto Hiroyuki,
Wada Taizo,
Takagi Masatoshi,
Imai Kohsuke,
Kanegane Hirokazu,
Morio Tomohiro
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16583
Subject(s) - plasma cell , multiple myeloma , plasmacytoma , lymph node , pathology , lymphoproliferative disorders , biology , antibody , medicine , immunology , cancer research , lymphoma
Jakovljevic G, Gasparov S, et al. Mast-cell sarcoma of the tibia. J Clin Pathol. 2007;60:424–5. 9. Krauth MT, Fodinger M, Rebuzzi L, Greul R, Chott A, Valent P. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Haematologica. 2007;92:e126–29. 10. Bugalia A, Abraham A, Balasubramanian P, Srivastava A, Nair S. Mast cell sarcoma of the small intestine: a case report. J Clin Pathol. 2011;64:1035–7. 11. Ma HB, Xu X, Liu WP, Chang H, Zeng F, Wang YC. Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol. 2011;94:491–4. 12. Auquit-Auckbur I, Lazar C, Deneuve S, Guillemet C, Cordel N, Blanchard F, et al. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol. 2012;36:779–82. 13. Falleti J, Borgia L, Lalinga AV, de Cecio R, Natella V, Patitucci G, et al. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis? Pathol Res Pract. 2012;208:683–6. 14. Georgin-Lavialle S, Aguilar C, Guieze R, Lhermitte L, Bruneau J, Fraitag S, et al. Mast cell sarcoma: a rare and aggressive entity–report of two cases and review of the literature. J Clin Oncol. 2013;31:e90–7. 15. Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, et al. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol. 2013;26:533–43. 16. Kim YS, Wu H, Pawlowska AB, BautistaQuach MA, Huang Q, Gaal K, et al. Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm. Am J Surg Pathol. 2013;37:453–8. 17. Bautista-Quach MA, Booth CL, Kheradpour A, Zuppan CW, Rowsell EH, Weiss L, et al. Mast cell sarcoma in an infant: a case report and review of the literature. J Pediatr Hematol Oncol. 2013;35:315–20. 18. Schwaab J, Horny HP, Jonescheit J, Metzgeroth G, Schafhausen P, Gaiser T, et al. Mast cell sarcoma mimicking metastatic colon carcinoma. Ann Hematol. 2014;93:1067–9. 19. He F, Horny HP, Boone J, Raza A, Griffith M, Hurley P, et al. Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis. Leuk Lymphoma. 2017;58:1515–7. 20. Yamashita A, Saito T, Akaike K, Arakawa A, Yoshida A, Kikuchi K, et al. Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation. Virchows Arch. 2017;470:583–8. 21. Ravanpay AC, Fromm JR, Edlefsen KL, Martin P, Chesnut R. The first report of human primary thoracic spine mast cell sarcoma: a case report. Clin Neuropathol. 2018;37:28–35. 22. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–25. 23. Valent, P Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematology Am Soc Hematol Educ Program. 2015;2015:98–105.